Recombinant biglycan promotes bone morphogenetic protein-induced osteogenesis

Journal of Dental Research

Volumn 93, Issue 4, 2014, Pages 406-411

  Miguez, P A ^a   Terajima, M ^a   Nagaoka, H ^a   Ferreira, J A R ^a   Braswell, K ^a   Ko, C C ^a   Yamauchi, M ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

bone regeneration; critical sized defect; growth factor; microcomputed tomography; proteoglycan; Smad 1 5 8

Indexed keywords

ACID PHOSPHATASE; ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; ALKALINE PHOSPHATASE; BGN PROTEIN, RAT; BIGLYCAN; BIOLOGICAL MARKER; BMP2 PROTEIN, RAT; BONE MORPHOGENETIC PROTEIN 2; COLLAGEN; GLUTATHIONE TRANSFERASE; GROWTH FACTOR; ISOENZYME; MADH9 PROTEIN, RAT; PROTEOGLYCAN; RECOMBINANT PROTEIN; SMAD1 PROTEIN; SMAD1 PROTEIN, RAT; SMAD5 PROTEIN; SMAD5 PROTEIN, RAT; SMAD8 PROTEIN; TARTRATE-RESISTANT ACID PHOSPHATASE; TISSUE SCAFFOLD;

ANIMAL; ARTICLE; BONE DENSITY; BONE DEVELOPMENT; BONE REGENERATION; CELL LINE; CHEMISTRY; CRITICAL-SIZED DEFECT; CULTURE TECHNIQUE; DRUG EFFECT; JAW DISEASE; MICRO-COMPUTED TOMOGRAPHY; PATHOLOGY; PATHOPHYSIOLOGY; RAT; SIGNAL TRANSDUCTION; SMAD 1/5/8; SPRAGUE DAWLEY RAT; TISSUE ENGINEERING;

BONE REGENERATION; CRITICAL-SIZED DEFECT; GROWTH FACTOR; MICROCOMPUTED TOMOGRAPHY; PROTEOGLYCAN; SMAD 1/5/8;

ACID PHOSPHATASE; ALKALINE PHOSPHATASE; ANIMALS; BIGLYCAN; BIOLOGICAL MARKERS; BONE DENSITY; BONE MORPHOGENETIC PROTEIN 2; BONE REGENERATION; CELL CULTURE TECHNIQUES; CELL LINE; COLLAGEN; GLUTATHIONE TRANSFERASE; ISOENZYMES; MANDIBULAR DISEASES; MAP KINASE SIGNALING SYSTEM; OSTEOGENESIS; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; SMAD1 PROTEIN; SMAD5 PROTEIN; SMAD8 PROTEIN; TISSUE ENGINEERING; TISSUE SCAFFOLDS; X-RAY MICROTOMOGRAPHY;

EID: 84896465167     PISSN: 00220345     EISSN: 15440591     Source Type: Journal    
DOI: 10.1177/0022034514521237     Document Type: Article

References (29)

1. Arosarena O, Collins W. Comparison of BMP-2 and -4 for rat mandibular bone regeneration at various doses. Orthod Craniofac Res. 2005 ; 8: 267-276
2. Berendsen AD, Fisher LW, Kilts TM, Owens RT, Robey PG, Gutkind JS, et al. Modulation of canonical Wnt signaling by the extracellular matrix component biglycan. Proc Natl Acad Sci U S A. 2011 ; 108: 17022-17027
3. Bianco P, Fisher LW, Young MF, Termine JD, Robey PG. Expression and localization of the two small proteoglycans biglycan and decorin in developing human skeletal and non-skeletal tissues. J Histochem Cytochem. 1990 ; 38: 1549-1563
4. Boskey AL, Spevak L, Doty SB, Rosenberg L. Effects of bone CS-proteoglycans, DS-decorin, and DS-biglycan on hydroxyapatite formation in a gelatin gel. Calcif Tissue Int. 1997 ; 61: 298-305
5. Chen XD, Fisher LW, Robey PG, Young MF. The small leucine-rich proteoglycan biglycan modulates BMP-4-induced osteoblast differentiation. FASEB J. 2004 ; 18: 948-958
6. Dayan D, Hiss Y, Hirshberg A, Bubis JJ, Wolman M. Are the polarization colors of picrosirius red-stained collagen determined only by the diameter of the fibers?. Histochemistry. 1989 ; 93: 27-29
7. Dickerman RD, Reynolds AS, Morgan BC, Tompkins J, Cattorini J, Bennett M. rh-BMP-2 can be used safely in the cervical spine: dose and containment are the keys!. Spine J. 2007 ; 7: 508-509
8. Fisher LW, Termine JD, Dejter SW, Whitson SW, Yanagishita M, Kimura JH, et al. Proteoglycans of developing bone. J Biol Chem. 1983 ; 258: 6588-6594
9. Gallea S, Lallemand F, Atfi A, Rawadi G, Ramez V, Spinella-Jaegle S, et al. Activation of mitogen-activated protein kinase cascades is involved in regulation of bone morphogenetic protein-2-induced osteoblast differentiation in pluripotent C2C12 cells. Bone. 2001 ; 28: 491-498
10. Garrett MP, Kakarla UK, Porter RW, Sonntag VK. Formation of painful seroma and edema after the use of recombinant human bone morphogenetic protein-2 in posterolateral lumbar spine fusions. Neurosurgery. 2010 ; 66: 1044-1049
11. Ghayor C, Ehrbar M, San Miguel B, Gratz KW, Weber FE. cAMP enhances BMP2-signaling through PKA and MKP1-dependent mechanisms. Biochem Biophys Res Commun. 2009 ; 381: 247-252
12. Junqueira LC, Bignolas G, Brentani RR. Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections. Histochem J. 1979 ; 11: 447-455
13. Kaku M, Mochida Y, Atsawasuwan P, Parisuthiman D, Yamauchi M. Post-translational modifications of collagen upon BMP-induced osteoblast differentiation. Biochem Biophys Res Commun. 2007 ; 359: 463-468
14. Kaneko H, Arakawa T, Mano H, Kaneda T, Ogasawara A, Nakagawa M, et al. Direct stimulation of osteoclastic bone resorption by bone morphogenetic protein (BMP)-2 and expression of BMP receptors in mature osteoclasts. Bone. 2000 ; 27: 479-486
15. Lee KB, Taghavi CE, Song KJ, Sintuu C, Yoo JH, Keorochana G, et al. Inflammatory characteristics of rhBMP-2 in vitro and in an in vivo rodent model. Spine (Phila Pa 1976). 2011 ; 36: E149 - E154
16. Miguez PA, Terajima M, Nagaoka H, Mochida Y, Yamauchi M. Role of glycosaminoglycans of biglycan in BMP-2 signaling. Biochem Biophys Res Commun. 2011 ; 405: 262-266
17. Mochida Y, Parisuthiman D, Yamauchi M. Biglycan is a positive modulator of BMP-2 induced osteoblast differentiation. Adv Exp Med Biol. 2006 ; 585: 101-113
18. Nakashima A, Katagiri T, Tamura M. Cross-talk between Wnt and bone morphogenetic protein 2 (BMP-2) signaling in differentiation pathway of C2C12 myoblasts. J Biol Chem. 2005 ; 280: 37660-37668
19. Neame PJ, Choi HU, Rosenberg LC. The primary structure of the core protein of the small, leucine-rich proteoglycan (PG I) from bovine articular cartilage. J Biol Chem. 1989 ; 264: 8653-8661
20. Parisuthiman D, Mochida Y, Duarte WR, Yamauchi M. Biglycan modulates osteoblast differentiation and matrix mineralization. J Bone Miner Res. 2005 ; 20: 1878-1886
21. Rawadi G, Vayssiere B, Dunn F, Baron R, Roman-Roman S. BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop. J Bone Miner Res. 2003 ; 18: 1842-1853
22. Schonherr E, Witsch-Prehm P, Harrach B, Robenek H, Rauterberg J, Kresse H. Interaction of biglycan with type I collagen. J Biol Chem. 1995 ; 270: 2776-2783
23. Selvig KA, Sorensen RG, Wozney JM, Wikesjo UM. Bone repair following recombinant human bone morphogenetic protein-2 stimulated periodontal regeneration. J Periodontol. 2002 ; 73: 1020-1029
24. Shields LB, Raque GH, Glassman SD, Campbell M, Vitaz T, Harpring J, et al. Adverse effects associated with high-dose recombinant human bone morphogenetic protein-2 use in anterior cervical spine fusion. Spine (Phila Pa 1976). 2006 ; 31: 542-547
25. Smucker JD, Rhee JM, Singh K, Yoon ST, Heller JG. Increased swelling complications associated with off-label usage of rhBMP-2 in the anterior cervical spine. Spine (Phila Pa 1976). 2006 ; 31: 2813-2819
26. Yan D, Gurumurthy A, Wright M, Pfeiler TW, Loboa EG, Everett ET. Genetic background influences fluoride's effects on osteoclastogenesis. Bone. 2007 ; 41: 1036-1044
27. Zara JN, Siu RK, Zhang X, Shen J, Ngo R, Lee M, et al. High doses of bone morphogenetic protein 2 induce structurally abnormal bone and inflammation in vivo. Tissue Eng Part A. 2011 ; 17: 1389-1399
28. Zellin G, Linde A. Importance of delivery systems for growth-stimulatory factors in combination with osteopromotive membranes: an experimental study using rhBMP-2 in rat mandibular defects. J Biomed Mater Res. 1997 ; 35: 181-190
29. Zhang M, Yan Y, Lim YB, Tang D, Xie R, Chen A, et al. BMP-2 modulates beta-catenin signaling through stimulation of Lrp5 expression and inhibition of beta-TrCP expression in osteoblasts. J Cell Biochem. 2009 ; 108: 896-905